NFKB1 and depressive symptom measurement: Depression-like effects are partially achieved by modifying the HPA axis’ malfunction, reestablishing neurotransmitter levels, and preventing neuronal death and neuroinflammation through SIRT1/NF-kB signaling pathway (Jiang et al., 2020a).